VC-backed Outpost Medicine hires chief medical officer
Indianapolis and London-based Outpost Medicine, a biopharmaceutical company focused on treating urologic and gastrointestinal disorders, has named Dr. Ian Mills as chief medical officer. Previously, Mills worked at Mitsubishi Tanabe Pharma Europe where he was head of clinical development. Outpost Medicine is backed by Frazier Healthcare Partners, Adams Street Partners, Novo Holdings A/S, Vivo Capital and Takeda Ventures.
4 December 2017•2 mins read
